Results 11 to 20 of about 142,658 (312)

Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype

Cells, 2021
Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance.
Els Beijer, Claudia Roodenburg-Benschop, Milou C. Schimmelpennink, Jan C. Grutters, Bob Meek, Marcel Veltkamp   +5 more
doaj   +1 more source

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE

BMC Pulmonary Medicine, 2023
Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decisions.
Gizal Nakshbandi, Catharina C. Moor, Katerina Antoniou, Vincent Cottin, Anna-Maria Hoffmann-Vold, Edwin A. Koemans, Michael Kreuter, Philip L. Molyneaux, Wim A. Wuyts, Marlies S. Wijsenbeek   +9 more
doaj   +1 more source

Interstitial lung disease [PDF]

European Respiratory Review, 2013
This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire   +4 more sources

A descriptive epidemiological study of interstitial lung disease in the United Kingdom general population [PDF]

, 2012
Interstitial lung disease (ILD) is a heterogeneous group of parenchymal lung disorders having varied histopathologies. Although histologically different, the ILDs have rather similar clinical presentations consisting of increasing dyspnea, a restrictive ...
Amar, Rajeev K.
core   +1 more source

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges. [PDF]

, 2022
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity and mortality. Lung fibrosis can be associated with lung cancer.
Jacques Cadranel, Cadranel, Jacques, Kewalramani, Namrata, Athol U. Wells, Machahua, Carlos, Manuela Funke-Chambour, Poletti, Venerino, Funke-Chambour, Manuela, Carlos Machahua, Wells, Athol U, Wells, Athol U., Namrata Kewalramani, Venerino Poletti   +12 more
core   +1 more source

Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review

European Respiratory Review, 2021
Over the past three decades, an increasing number of publications have reported the association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA) or ANCA-associated vasculitis (AAV). With this increased awareness, we
Suha Kadura, Ganesh Raghu
doaj   +1 more source

Lung Cancer in Pulmonary Fibrosis: Tales of Epithelial Cell Plasticity [PDF]

, 2011
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis.
Königshoff, M., Melanie Königshoff, Königshoff, Melanie   +2 more
core   +1 more source

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases [PDF]

, 2022
Interstitial lung diseases represent a heterogeneous and wide group of diseases in which factors leading to disease initiation and progression are not fully understood.
Gramegna, Andrea, Antonio Voza, Anoop M. Nambiar, Francesco Blasi, Andrea Gramegna, Philip L. Molyneaux, Amati, Francesco, Molyneaux, Philip L., Molyneaux, Philip L, Anna Stainer, Stefano Aliberti, Blasi, Francesco, Aliberti, Stefano, Paolo Spagnolo, Voza, Antonio, Giulia Suigo, Francesco Amati, Marco Mantero, Edoardo Simonetta, Nambiar, Anoop M, Justin Oldham, Suigo, Giulia, Simonetta, Edoardo, Cariboni, Umberto, Spagnolo, Paolo, Mantero, Marco, Umberto Cariboni, Oldham, Justin, Stainer, Anna, Nambiar, Anoop M.   +29 more
core   +3 more sources

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

EJNMMI Research, 2019
Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the
Milou C. Schimmelpennink, Adriane D. M. Vorselaars, Marcel Veltkamp, Ruth G. M. Keijsers   +3 more
doaj   +1 more source

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

Respiratory Research, 2022
Background Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease (ILD) with a variable disease course and prognosis ranging from inflammatory and self-limiting to irreversible and progressive pulmonary fibrosis.
Thomas Skovhus Prior, Julia Wälscher, Benjamin Gross, Elisabeth Bendstrup, Michael Kreuter   +4 more
doaj   +1 more source